Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation

被引：16

作者：

Riboldi, Giulietta Maria ^{[1
]}

Palma, Jose-Alberto ^{[2
]}

Cortes, Etty ^{[3
]}

Iida, Megan A. ^{[3
,4
]}

Sikder, Tamjeed ^{[3
,4
]}

Henderson, Brooklyn ^{[1
]}

Raj, Towfique ^{[4
,5
]}

Walker, Ruth H. ^{[6
,7
]}

Crary, John F. ^{[3
,4
]}

Kaufmann, Horacio ^{[2
]}

Frucht, Steven ^{[1
]}

机构：

[1] NYU, Sch Med, Dept Neurol, Fresco Inst Parkinsons & Movement Disorders, New York, NY USA

[2] NYU, Sch Med, Dept Neurol, Dysauton Ctr, New York, NY USA

[3] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA

[4] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA

[6] James J Peters Vet Affairs Med Ctr, Bronx, NY USA

[7] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA

来源：

MOVEMENT DISORDERS | 2019年 / 34卷 / 07期

基金：

美国国家卫生研究院;

关键词：

PARKINSONS-DISEASE; RISK; PENETRANCE; VARIANTS;

D O I：

10.1002/mds.27710

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1080 / 1082

页数：3

共 50 条

[31] Lower cognitive performance in healthy G2019S LRRK2 mutation carriers
Thaler, Avner
Mirelman, Anat
Gurevich, Tanya
Simon, Ely
Orr-Urtreger, Avi
Marder, Karen
Bressman, Susan
Giladi, Nir
NEUROLOGY, 2012, 79 (10) : 1027 - 1032
[32] Reply: Unilateral Pallidotomy in a Patient with Parkinsonism and G2019S LRRK2 Mutation
Schuepbach, M.
Lohman, E.
Brice, A.
MOVEMENT DISORDERS, 2009, 24 (05) : 792 - 792
[33] Postural control alterations in healthy LRRK2 G2019S mutation carriers
Giladi, N.
Beck, Y.
Brockmann, K.
Berg, D.
War, B. J.
Aasly, J.
Sunyer, C. Pont
Vilas, D.
Rao, A. K.
Marder, K. S.
Sunders-Pullman, R.
Bressman, S. B.
Orr-Urtreger, A.
Hausdorff, J. M.
Mirelman, A.
MOVEMENT DISORDERS, 2015, 30 : S404 - S404
[34] Is the G2019S LRRK2 mutation common in all southern European populations?
Papapetropoulos, S.
Adi, N.
Shehadeh, L.
Bishopric, N.
Singer, C.
Argyriou, A. A.
Chroni, E.
MOVEMENT DISORDERS, 2007, 22 : S133 - S133
[35] Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
Saunders-Pullman, Rachel
Mirelman, Anat
Wang, Cuiling
Alcalay, Roy N.
Luciano, Marta San
Ortega, Robert
Raymond, Deborah
Mejia-Santana, Helen
Ozelius, Laurie
Clark, Lorraine
Orr-Utreger, Avi
Marder, Karen
Giladi, Nir
Bressman, Susan B.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (09): : 670 - 678
[36] G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice
Novello, Salvatore
Arcuri, Ludovico
Dovero, Sandra
Dutheil, Nathalie
Shimshek, Derya R.
Bezard, Erwan
Morari, Michele
NEUROBIOLOGY OF DISEASE, 2018, 120 : 21 - 33
[37] Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
Vilas, Dolores
Ispierto, Lourdes
Alvarez, Ramiro
Pont-Sunyer, Claustre
Jose Marti, Maria
Valldeoriola, Francesc
Compta, Yaroslau
de Fabregues, Oriol
Hernandez-Vara, Jorge
Puente, Victor
Calopa, Matilde
Jauma, Serge
Campdelacreu, Jaume
Aguilar, Miquel
Quilez, Pilar
Casquero, Pilar
Lomena, Francisco
Rios, Jose
Tolosa, Eduardo
PARKINSONISM & RELATED DISORDERS, 2015, 21 (10) : 1170 - 1176
[38] No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy
Tedde, Andrea
Bagnoli, Silvia
Cellini, Elena
Nacmias, Benedetta
Piacentini, Silvia
Sorbi, Sandro
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2007, 27 (07) : 877 - 881
[39] The LRRK2 G2019S Mutation Predisposes Parkinson's Disease Patients to Cancer
Inzelberg, Rivka
Cohen, Oren S.
Aharon-Peretz, Judith
Schlesinger, Ilana
Yaakov, Zichron
Gershoni-Baruch, Ruth
Djaldetti, Ruth
Nitzan, Zeev
Ephraty, Lilach
Tunkel, Olga
Kozlova, Evgenya
Inzelberg, Lilah
Schechtman, Edna
Kaplan, Natali
Friedman, Eitan
Hassin-Baer, Sharon
NEUROLOGY, 2011, 76 (09) : A17 - A17
[40] The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews
Thaler, Avner
Ash, Elissa
Gan-Or, Ziv
Orr-Urtreger, Avi
Giladi, Nir
JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (11) : 1473 - 1482

← 1 2 3 4 5 →